文献速递儿科与产科急症呼吸衰竭与机械通气

持续充气与间歇正压通气对极早产儿支气管肺发育不良或死亡的影响:SAIL随机临床试验

Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants: The SAIL Randomized Clinical Trial.
PubMed 文献 · JAMA · 2019-01-01
一句话结论极早产儿出生复苏时使用2次持续充气较标准间歇正压通气未降低36周矫正胎龄时BPD或死亡风险,且48小时内死亡更多(7.4% vs 1.4%),作者认为不支持使用持续充气。

SAIL为在9个国家18个新生儿ICU开展的非盲随机临床试验(2014年8月至2017年9月,随访至2018年2月15日),纳入23至26周胎龄、出生时需复苏且呼吸努力不足或心动过缓的早产儿,计划入组600例,因预设不良结局审查在入组426例后终止。干预为使用T型管和面罩进行最多2次持续充气,最大峰压25 cm H2O、每次15秒(n=215);对照为标准间歇正压通气(n=211)。主要终点36周矫正胎龄时BPD或死亡在持续充气组137例(63.7%)vs 标准组125例(59.2%),校正风险差4.7%(95%CI -3.8%至13.1%;P=0.29)。48小时内死亡在持续充气组16例(7.4%)vs 标准组3例(1.4%),校正风险差5.6%(95%CI 2.1%至9.1%;P=0.002);盲法裁定发现早期死亡可能归因于复苏的比例失衡(持续充气组11/16;标准组1/3)。27项次要疗效终点中26项无显著差异。

要点

  • 极早产儿(23–26周)出生复苏使用2次持续充气(峰压25 cm H2O、每次15秒,T型管和面罩)较间歇正压通气未降低36周BPD或死亡(63.7% vs 59.2%;aRD 4.7%,95%CI -3.8%至13.1%;P=0.29)。
  • 持续充气组48小时内死亡高于标准组(7.4% vs 1.4%;aRD 5.6%,95%CI 2.1%至9.1%;P=0.002),盲法裁定早期死亡可能归因于复苏者持续充气组11/16、标准组1/3。
  • 27项预设次要疗效终点中26项无显著差异。
  • 作者结论:这些发现不支持在极早产儿中使用持续充气通气,但试验提前终止限制了确定性结论。

适用人群与场景

  • 23至26周胎龄、出生时需复苏且呼吸努力不足或心动过缓的早产儿,在新生儿ICU复苏场景。

处置流程与药物剂量

  • 实验干预:使用T型管和面罩进行最多2次持续充气,最大峰压25 cm H2O,每次持续15秒(n=215)。
  • 标准复苏:间歇正压通气(n=211)。

红旗征与不能漏的情况

  • 持续充气组48小时内死亡16例(7.4%)vs 标准组3例(1.4%),校正风险差5.6%(95%CI 2.1%至9.1%;P=0.002)。
  • 盲法裁定发现早期死亡可能归因于复苏的比例失衡:持续充气组11/16,标准组1/3。

研究设计与关键结果

  • 非盲随机临床试验,在9个国家18个新生儿ICU开展,2014年8月至2017年9月入组,随访至2018年2月15日;计划入组600例,因预设不良结局审查在入组426例后终止。
  • 共460例随机(平均胎龄25.30周,SD 0.97;女性50.2%),426例(92.6%)完成试验。
  • 主要终点36周矫正胎龄时BPD或死亡:持续充气组137例(63.7%)vs 标准组125例(59.2%),校正风险差4.7%(95%CI -3.8%至13.1%;P=0.29)。
  • 48小时内死亡:持续充气组16例(7.4%)vs 标准组3例(1.4%),校正风险差5.6%(95%CI 2.1%至9.1%;P=0.002)。
  • 27项预设次要疗效终点中26项在36周矫正胎龄时无显著差异。

证据类型、等级与局限

  • 证据类型:随机临床试验(非盲)。
  • 局限:试验在入组426例后提前终止,限制确定性结论(原文结论指出early termination of the trial limits definitive conclusions)。

对床旁实践的改变

  • 作者结论:这些发现不支持在极早产儿中使用持续充气通气;但试验提前终止限制了确定性结论。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Preterm infants must establish regular respirations at delivery. Sustained inflations may establish lung volume faster than short inflations.

OBJECTIVE: To determine whether a ventilation strategy including sustained inflations, compared with standard intermittent positive pressure ventilation, reduces bronchopulmonary dysplasia (BPD) or death at 36 weeks' postmenstrual age without harm in extremely preterm infants.

DESIGN, SETTING, AND PARTICIPANTS: Unmasked, randomized clinical trial (August 2014 to September 2017, with follow-up to February 15, 2018) conducted in 18 neonatal intensive care units in 9 countries. Preterm infants 23 to 26 weeks' gestational age requiring resuscitation with inadequate respiratory effort or bradycardia were enrolled. Planned enrollment was 600 infants. The trial was stopped after enrolling 426 infants, following a prespecified review of adverse outcomes.

INTERVENTIONS: The experimental intervention was up to 2 sustained inflations at maximal peak pressure of 25 cm H2O for 15 seconds using a T-piece and mask (n = 215); standard resuscitation was intermittent positive pressure ventilation (n = 211).

MAIN OUTCOME AND MEASURES: The primary outcome was the rate of BPD or death at 36 weeks' postmenstrual age. There were 27 prespecified secondary efficacy outcomes and 7 safety outcomes, including death at less than 48 hours.

RESULTS: Among 460 infants randomized (mean [SD] gestational age, 25.30 [0.97] weeks; 50.2% female), 426 infants (92.6%) completed the trial. In the sustained inflation group, 137 infants (63.7%) died or survived with BPD vs 125 infants (59.2%) in the standard resuscitation group (adjusted risk difference [aRD], 4.7% [95% CI, -3.8% to 13.1%]; P = .29). Death at less than 48 hours of age occurred in 16 infants (7.4%) in the sustained inflation group vs 3 infants (1.4%) in the standard resuscitation group (aRD, 5.6% [95% CI, 2.1% to 9.1%]; P = .002). Blinded adjudication detected an imbalance of rates of early death possibly attributable to resuscitation (sustained inflation: 11/16; standard resuscitation: 1/3). Of 27 secondary efficacy outcomes assessed by 36 weeks' postmenstrual age, 26 showed no significant difference between groups.

CONCLUSIONS AND RELEVANCE: Among extremely preterm infants requiring resuscitation at birth, a ventilation strategy involving 2 sustained inflations, compared with standard intermittent positive pressure ventilation, did not reduce the risk of BPD or death at 36 weeks' postmenstrual age. These findings do not support the use of ventilation with sustained inflations among extremely preterm infants, although early termination of the trial limits definitive conclusions.

TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT02139800.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Kirpalani H, Ratcliffe SJ, Keszler M, et al. Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants: The SAIL Randomized Clinical Trial. JAMA. 2019. PMID: 30912836. doi:10.1001/jama.2019.1660

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。